This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Uniquest Pty Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Muhammad Sofian Asi Sihombing: Innovator in Antimicrobial Therapeutics
Introduction
Muhammad Sofian Asi Sihombing is a notable inventor based in Singapore, SG. He has made significant contributions to the field of therapeutic compounds, particularly in the development of antimicrobial agents. His innovative work focuses on lipopeptide compounds that have the potential to combat bacterial infections.
Latest Patents
Sihombing holds a patent for "Lipopeptide compounds and their use." This invention pertains to certain lipopeptide compounds comprising a cyclic peptide with a lipid side chain, collectively referred to as 'LP compounds.' These compounds exhibit antimicrobial properties, especially against bacteria. The patent also covers pharmaceutical compositions that utilize these compounds for treating diseases mediated by microbes, particularly bacterial infections.
Career Highlights
Sihombing is associated with Uniquest Pty Limited, where he continues to advance his research in therapeutic compounds. His work has the potential to impact the medical field significantly, especially in the treatment of bacterial diseases.
Collaborations
He collaborates with esteemed colleagues such as Rustum S Boyce and Joseph Cherian, contributing to a dynamic research environment that fosters innovation in antimicrobial therapies.
Conclusion
Muhammad Sofian Asi Sihombing is a pioneering inventor whose work in lipopeptide compounds is paving the way for new antimicrobial treatments. His contributions are vital in addressing the challenges posed by bacterial infections.